Cardiovascular-Metabolic Diagnostics

Roche Pharma

Switzerland

Roche is a global healthcare company headquartered in Switzerland that combines life-changing diagnostics and pharmaceutical medicines to address complex healthcare challenges. The company operates through two integrated divisions focused on diagnostics and pharmaceuticals, jointly targeting three major disease areas: cancer, cardiovascular-metabolic diseases, and neurological diseases, which account for nearly 50 percent of global disease burden by 2035. Roche develops innovative solutions for disease prevention through early detection of high-risk patients, disease management through accurate diagnosis and targeted medicines, and disease cure through curative pharmaceutical interventions. The company maintains a strong commitment to innovation in machine learning and artificial intelligence for drug discovery and development. With operations spanning more than 110 countries, Roche emphasizes ethical leadership, quality standards, and sustainable business practices. The company is recognized internationally for its commitment to innovation, patient-centered approaches, and corporate responsibility.